Patent ID: 8067043

Claim:
A pharmaceutical composition for treating hyperlipidemia, the composition comprising: Glycine max seed extract in an amount of 10-15% by weight of the composition, wherein the Glycine max seed extract contains about 40% isoflavones; Plumago zeylanica root extract in an amount of 10-15% by weight of the composition, wherein the Plumago zeylanica root extract contains about 0.08-0.15% alkaloids; Terminalia arjuna bark extract in an amount of 10-15% by weight of the composition, wherein the Terminalia arjuna bark extract contains about 25% tannins and greater than 1% arjunic acid; Trigonella - foenum graceum seed extract in an amount of 10-15% by weight of the composition, wherein the Trigonella - foenum graceum seed extract contains about 10% saponins; Coleus forskohlii root extract in an amount of 10-15% by weight of the composition, wherein the Coleus forskohlii root extract contains greater than 2.5% forskolin; Commiphora mukul resin extract in an amount of 10-15% by weight of the composition, wherein the Commiphora mukul resin extract contains about 2.5-10% guggal sterones; Camellia sinensis leaf extract in an amount of 10-15% by weight of the composition, wherein the Camellia sinensis leaf extract contains greater than 45% polyphenols; and Azadiracta indica bark extract in an amount of 5-7.5% by weight of the composition, wherein the Azadiracta indica bark extract contains about 2.5% bitters.